Molecular Medicine Tri-Conference in the News
With New Tools, Physicians Become Better NGS Customers
Mar 15 | GEN | Scientists who study how physicians use genomics data in personalized medicine presented their recent work at the Cambridge Healthtech Molecular Med Tri Conference in San Francisco.
Startup Guardant Health Developing NGS-based Assays to Assess Circulating Tumor DNA
Mar 5 | Clinical Sequencing News | At last month's Molecular Medicine Tri-Conference in San Francisco, Dave Hoon, the director of the John Wayne Cancer Institute's sequencing center and an advisor to the company, presented a validation study he is doing with the company, results of which have been analyzed in around 250 patients so far.
Singapore's MiRxes Spins Out from A*Star with Novel qPCR Assay Platform for microRNA Analysis
Feb 27 | MiRxes CTO Lihan Zhou and other company officials presented posters describing the mSMRT-qPCR technology and MiRxes' efforts to apply it to the non-invasive early detection of gastric and breast cancers earlier this month at Cambridge Healthtech Institute's Molecular Medicine Tri-Conference in San Francisco.
Q&A: UMich's Muneesh Tewari on miRNAs as Cancer Biomarkers, ddPCR as Detection Method
Feb 27 | PCR Insider | Earlier this month at Cambridge Healthtech Institute's Molecular Medicine Tri-Conference in San Francisco, Tewari presented some of his recent work in this area. He highlighted the fact that research on circulating miRNAs as cancer biomarkers is now nearing the six-year mark, and reviewed what researchers have learned and where they go from here.
UCSF, QB3 Team Developing PCR-Activated Cell Sorting Method; Startup Mission Bio Eyes Market
Feb 20 | PCR Insider | Abate shared details of the new method in a presentation last week at Cambridge Healthtech Institute's Molecular Medicine Tri-Conference in San Francisco.
MolecularHealth Readies NGS-based Oncology Assays
Feb 19 | Clinical Sequencing News | MolecularHealth is in the final stages of validating a targeted sequencing panel and an exome sequencing test for cancer patients and plans to launch the tests within the next couple of months, the company told Clinical Sequencing News at last week's Molecular Medicine Tri Conference in San Francisco.
Patient Stratification in Clinical Trials Emerges as Theme at MMTC
Feb 17 | Bio-IT World | The 21st annual Molecular Medicine Tri-Conference in San Francisco featured some intense scrutiny of one area where genetic knowledge is ready to make an impact today: better defining the best patient populations for treatment during clinical trials.
At Threshold of Detection, False-Positive Droplets a Nuisance in ddPCR
Feb 13 | PCR Insider | In a presentation this week at Cambridge Healthtech Institute's Molecular Medicine Tri-Conference in San Francisco, Strain stated definitively that real-time PCR is "not good enough" for the detection of residual HIV nucleic acids in patient samples, and provided additional evidence generated in his lab that droplet digital PCR is an ideal modality for this application.
Rheonix Unveils 'Channel-Free' Microfluidic Device for Molecular Testing Platform
Feb 13 | PCR Insider | In a presentation in the Biospecimen Science and Sample Prep program of Cambridge Healthtech Institute's Molecular Medicine Tri-Conference, held here this week, Richard Montagna, Rheonix's senior vice president for scientific and clinical affairs, discussed the company's latest microfluidics breakthrough, the Smart FilmCARD.
Denmark's Anapa Biotech Applies Primer-Modification Tech to MRSA Assay; Discloses NextGen Molecule
Feb 13 | PCR Insider | Schneider discussed these developments at a presentation during the "PCR for Molecular Medicine" track at Cambridge Healthcare Institute's Molecular Medicine Tri-Conference, held here this week.
Sample Prep Proving a Key Consideration in Clinical NGS Testing
Feb 12 | Clinical Sequencing News | Increasingly, issues related to sample prep, not sequencing technology, are becoming the hurdle for developing clinical next-gen sequencing-based tests, researchers from Quest Diagnostics and the US Centers for Disease Control and Prevention said at this week's Molecular Medicine Tri Conference in San Francisco.
Informatics Tools for the Big Data Challenge
Jan 03 | Bio-IT World |Informatics tools are essential to enabling life sciences research, and at the Molecular Medicine Tri-Conference next month in San Francisco, a host of leaders across the industry will share their best practices for making sense of the wealth.
Clinical Sequencing at the Molecular Medicine Tri-Conference
Jan 02 | Clinical Informatics News | 2014 will be the biggest year yet for the clinical use of genetic information. At the Molecular Medicine Tri-Conference in February, speakers from biotech industry and research will discuss the future of clinical sequencing, whether in cancer treatment, diagnostics, prenatal testing, or just general care.
Maven Biotech Undertakes Asset Sale to Deliver Label-free Detection Technology into 'Stronger Hands'
Dec 17 | BioArray News| Blose said that Maven's technology is "already receiving attention" from undisclosed parties, and that BioMed intends to meet with potential partners at the upcoming JP Morgan Healthcare Conference in San Francisco in January, and again at the Molecular Medicine Tri-Conference, which will also be held in San Francisco, in February.